Polypharmacy in older adults with cancer

Ronald J. Maggiore, Cary P. Gross, Arti Hurria

    Research output: Contribution to journalReview article

    111 Scopus citations

    Abstract

    The definition of "polypharmacy" ranges from the use of a large number of medications; the use of potentially inappropriate medications, which can increase the risk for adverse drug events; medication underuse despite instructions to the contrary; and medication duplication. Older adults are particularly at risk because they often present with several medical conditions requiring pharmacotherapy. Cancerrelated therapy adds to this risk in older adults, but few studies have been conducted in this patient population. In this review, we outline the adverse outcomes associated with polypharmacy and present polypharmacy definitions offered by the geriatrics literature. We also examine the strengths and weaknesses of these definitions and explore the relationships among these definitions and what is known about the prevalence and impact of polypharmacy.

    Original languageEnglish (US)
    Pages (from-to)507-522
    Number of pages16
    JournalOncologist
    Volume15
    Issue number5
    DOIs
    StatePublished - 2010

    Keywords

    • Cancer
    • Geriatrics
    • Medications
    • Oncology
    • Polypharmacy
    • Therapy

    ASJC Scopus subject areas

    • Oncology
    • Cancer Research

    Fingerprint Dive into the research topics of 'Polypharmacy in older adults with cancer'. Together they form a unique fingerprint.

  • Cite this

    Maggiore, R. J., Gross, C. P., & Hurria, A. (2010). Polypharmacy in older adults with cancer. Oncologist, 15(5), 507-522. https://doi.org/10.1634/theoncologist.2009-0290